4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
4.640
-0.030 (-0.64%)
At close: Feb 21, 2025, 4:00 PM
4.870
+0.230 (4.96%)
After-hours: Feb 21, 2025, 5:44 PM EST
4D Molecular Therapeutics Employees
4D Molecular Therapeutics had 147 employees as of December 31, 2023. The number of employees increased by 7 or 5.00% compared to the previous year.
Employees
147
Change (1Y)
7
Growth (1Y)
5.00%
Revenue / Employee
$116
Profits / Employee
-$976,054
Market Cap
214.50M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 147 | 7 | 5.00% |
| Dec 31, 2022 | 140 | 16 | 12.90% |
| Dec 31, 2021 | 124 | 41 | 49.40% |
| Dec 31, 2020 | 83 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
FDMT News
- 3 days ago - 4DMT to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 days ago - 4D Molecular Therapeutics: A Smart Bet On Long-Term VEGF Suppression - Seeking Alpha
- 12 days ago - Eye Disease Focused 4D Molecular Therapeutics Lays Out 52-Week Results From Wet AMD Study - Benzinga
- 13 days ago - 4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program - GlobeNewsWire
- 3 months ago - 4DMT Reports Third Quarter 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones - GlobeNewsWire
- 3 months ago - 4D Molecular Therapeutics Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Encourages Investor Participation - Accesswire
- 4 months ago - 4D Molecular Therapeutics Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Investors To Reach Out - Accesswire
- 4 months ago - 4D Molecular Therapeutics Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Impacted Investors To Reach Out - Accesswire